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A wide range of fungi have been associated with Allergic Fungal Sinusitis (AFS) or Eosinophilic 
fungal rhinosinusitis ( EFRS) as it is known in some institutions. To our knowledge, this is the first 
reported case of aggressive, invasive AFS due to Acremonium species occurring in an 
immunocompetent patient and leading to unilateral visual loss. Literature on AFS is reviewed. 
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Introduction   
 
Allergic fungal sinusitis (AFS) or Eosinophilic 
fungal rhinosinusitis( EFRS) as it is known in 
some institutions, was first appreciated by 
Millar et al in 1981 due to its histological 
similarity to Allergic bronchopulmonary 
aspergillosis (ABPA)1. Criteria for the diagnosis 
of AFS were proposed by Bent and Kuhn2 in 
1994. They found five characteristics in all 15 
patients they reported: These were; 
1. Evidence of type 1 hypersensitivity.  
2. Nasal polyps. 
3. Characteristic CT scan findings.  
4. Eosinophilic mucus.  
5. Demonstration of fungi.  
 
There are six associated features. They include: 
1. Asthma.  
2. Unilateral predominance.  
3. Radiographic bone erosion.  
4. Fungal culture.  
5. Charcot-Leyden crystals and serum 
eosinophilia.  
 
Controversy exists as to whether this is an IgE 
mediated disease or not. Because the presence 
of eosinophils in the allergic mucin, not a type 1 
hypersensitivity, is probably the common 
denominator in the pathophysiology of AFS, the 
Mayo Clinic group proposed a change in the 
name from Allergic fungal sinusitis to 
Eosinophilic fungal rhinosinusitis3,4. 
 
A wide range of fungi have been shown to be 
associated with AFS. These include Alternaria, 
Aspergillus sp. and various dematiaceous fungi 
such as Bipolaris and Culvulari5. Visual loss in  
 
 
AFS is uncommon6. To our knowledge, we 
report the first case of AFS caused by 
Acremonium species leading to a unilateral 
visual loss and we review the literature on AFS. 
 
Case report  
 
A 48 year old immunocompetent lady presented 
to her general practitioner (GP) with a three 
week history of unilateral right-sided nasal 
obstruction and headaches localized to the right 
frontal and occipital areas. The GP requested 
plain film x-rays which showed opacification of 
all sinuses on the right. She was commenced on 
Co-Amoxiclav and nasal decongestant drops, 
but a week later suffered sudden blindness in the 
right eye and an aggravation of symptoms of 
nasal obstruction and headaches. After urgent 
referral to an otolaryngologist, a CT scan (figure 
1) of the sinuses was performed. This showed 
opacification of the right frontal, ethmoid and 
both sphenoid sinuses. Thinning of the right 
lamina papyracea and widening of right 
infindibulum was present. MRI showed (figure 
2a & b) a hypo-intense mass extending into the 
right anterior clinoid process and compressing 
the optic nerve. There was no intracranial 
extension and the cavernous sinuses appeared 
normal.  Both CT and MRI had features 
consistent with fungal sinusitis. 
 
The patient went for an endoscopic examination 
under anaesthesia and biopsy.  PAS stains 
showed thin fungal pseudohyphae and the final 
culture grew Acremonium species.  She was 
started on intravenous Amphotericin B and a 
week later on corticosteroids. The reason for the 
delay was the invasive nature of the disease with 
fulminant fungal sinusitis not completely 
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excluded. A complete spheno-ethmoidectomy 
was performed after the initial culture results 
and complete macroscopic clearance was 
obtained. She continued with intravenous 
Amphoteracyn-B for another week and was 
discharged on oral Fluconazole and systemic 
corticosteroids.  She has since regained full 
peripheral vision. 
 
Discussion:  
 
Fungal sinusitis in immunocompetent patients is 
not a rare condition7,8. Five basic diagnostic 
categories of fungal rhinosinusitis disorders are 
recognised. Three types of fungal rhinosinusitis 
are true tissue-invasive infectious diseases: 
acute necrotising fungal rhinosinusitis, chronic 
invasive fungal rhinosinusitis, and 
granulomatous invasive (indolent) fungal 
rhinosinusitis. The two non-invasive fungal 
rhinosinusitis disorders are fungal ball (sinus 
mycetoma) and allergic fungal sinusitis (AFS).  
AFS, indolent and fungal ball are usually found 
in immunocompetent individuals 7,9. His 
classification does not take into account the 
acute fulminant type which has been reported by 
other authors 10,11 
 
The patient was classified as allergic fungal 
sinusitis based on clinical features, 
immunocompetence, radiological features, 
mycologic findings and presence of 
macroscopic allergic mucin.  Although AFS has 
been described since the early 1980s, there are 
still no established criteria for diagnosis and 
management.  Most authors take into account 
presence of atopy, characteristic radiographic 
findings, positive fungal culture and stain, in 
addition to presence of allergic mucin12, 13. 
Currently it appears that presence of more than 
one of these features may satisfy the diagnosis 
of AFS and not just the presence of one factor. 
 
Controversy surrounds the aetiology and 
pathogenesis of fungal sinusitis. Non-invasive 
fungal sinusitis usually occurs in individuals 
with a poorly draining maxillary sinus. Hamilos 
et al14 postulates six steps in the pathogenesis of 
EFRS which also emphasise the role of the 
Eosinophil. 1) The host becomes sensitised to 
fungal antigens. 2) fungal spores become 
trapped in nasal or sinus mucus and germinate 
into viable hyphae. 3) The large local fungal 
load elicits a localised immune response; this 
may explain disease localisation. 4) Eosinophils 
attack fungal hyphae and degranulate. 5) the 
eosinophilic inflammatory process releases 
multiple cytokines and growth factors, which 
may contribute to airway remodelling and nasal 
polyp formation. 6) Damage occurs to mucosa, 
facilitating bacterial penetration of the mucosa 
that leads to bacterial infection and further 
perpetuates the inflammatory process. 
 
 A wide range of fungi have been shown to be 
associated with AFS.  Aspergillus is the most 
prevalent pathogen in both invasive and non-
invasive fungal sinusitis 8,12,.  .Other causative 
organisms include Alternaria species, 
Curvularia lunata, Candida albicans, Bipolaris 
species 13. This is the first case to our knowledge 
of AFS being caused by Acremonium species 
and leading to visual loss. Acremonium species 
are environmentally widespread as saprobes in 
soil and as pathogens of plants and insects and 
rarely are opportunistic pathogens of humans 
and other mammals.  Although definitive 
identification of these species requires culture, 
they often can be identified provisionally in 
tissue sections by a combination of histologic 
features, including hyaline septate hyphae and 
characteristic reproductive structures known as 
phialides and phialoconidia. Acremonium 
species have been associated with diseases like 
keratomycosis and mycetoma  
 
Involvement of the orbit in fungal sinusitis 
forms a major component of the 
symptomatology of the patients. Therefore most 
patients do present to the Ophthalmologist first 
and then referred to the Otolaryngologist. Carter 
and associates looked at the ophthalmic 
manifestations of allergic fungal sinusitis and all 
of their six patients had proptosis. One patient 
had symptomatic diplopia and the other had 
visual loss15. The index patient had complete 
visual loss in the right eye and this is the most 
devastating ophthalmic symptom although it 
does not appear to be the common presenting 
ophthalmic symptom. 
 
Three modes of treatment are generally 
employed in managing AFS and these are 
surgery, antifungals and corticosteroids. Kuhn et 
al 3 highlights the role of each mode of treatment 
and he also discusses the role of immunotherapy 
which though it has been described as effective 
means of controlling AFS, can actually worsen 
the patients’ symptoms if therapy is started 
before a ‘significant antigenic’ load is removed. 
Surgery is the mainstay mode of treatment 
coupled with corticosteroids especially where 
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there is visual loss. Antifungals are naturally 
used where there is demonstration of fungi in 
the specimens but their role is unclear. 
 
Conclusion 
 
This is to our knowledge, the first case of 
invasive AFS due to Acremonium species 
leading to unilateral visual loss. Knowledge of 
AFS continues to evolve and an understanding 
on the pathogenesis of this mysterious disease 
will in future help us diagnose it more 
efficiently and of course manage it properly. At 
the moment a combination of vigilance, 
radiological and histological methods are quite 
helpful by way of diagnosis and the treatment 
methods described above together with close 
follow up are essential in managing the 
condition. 
 
References 
 
1. Millar JW, Johnston A, Lamb D. Allergic 
aspergillus of the maxillary sinus. Thorax. 
1981; 36: 710. 
2. Bent JP, Kuhn FA. The diagnosis of Allergic 
fungal sinusitis. Otolaryngol Head Neck Surg 
. 1994, 111: 580-588.\ 
3. Braun H, Buzina W, Freudenschuss K, Beham 
A, and Stammberger H. ‘ Eosinophilic fungal 
rhinosinusitis’ : a common disorder in 
Europe? Laryngoscope. 2003 Feb;113 (2) : 
264-9. 
4. Ponikau JU, Sherris DA, Kern EB et al. The 
diagnosis and incidence of Allergic fungal 
sinusitis. Mayo Clin Proc 1999; 74: 877-884. 
5. Kuhn FA and Swain Jr R. Allergic fungal 
sinusitis: diagnosis and treatment. Current 
opinion in Otolaryngology & Head and Neck 
Surgery. 2003, 11: 1-5. 
 
6. Graham SM and Carter KD. Response of 
visual loss in allergic fungal sinusitis to oral 
corticosteroids. Ann Otol Rhinol Laryngol. 
2005 Mar; 114 (3): 247-9. 
7. Uri N, Cohen-Kerem R, Elmalah I, Doweck I, 
Greenberg E. Classification of fungal sinusitis 
in immunocompetent patients. Otolaryngol  
Head Neck Surg. 2003 Oct; 129(4): 372-8. 
8. Siddiqui AA, Shah AA and Bashir SH. 
Craniocerebral aspergillosis of sinonasal orgin 
in immunocompetent patients: clinical 
spectrum and outcome in 25 cases. 
Neurosurgery. 2004 Sep; 55 ( 3): 602-11. 
9. Schubert MS. Allergic fungal sinusitis. 
Otolaryngol Clin North Am. 2004 Apr; 33 (2): 
227-37. 
10. Morpeth JF, Rupp NT, Dolen WK, Bent JP 
and Kuhn FA. Fungal sinusitis: update. Ann 
Allergy Asthma Immunol. 1996 Feb; 76 (2): 
128-39. 
11. Malani PN and Kauffman CA. Invasive and 
Allergic fungal sinusitis. Curr Infect Dis Res. 
2002 Jun; 4 (3): 225-232. 
12. Rains BM 3rd and Mineck CW. Treatment of 
Allergic fungal sinusitis with high dose 
itraconazole. Am J Rhinol . 2003 Jan-Feb; 
17(1): 1-8. 
13. Hutchton DM. Allergic fungal sinusitis: an 
otolaryngologic perspective. Allergy Asthma 
Proc. 2003 Sep-Oct; 24 (5): 307-11. 
14. Hamilos DW and Lund VJ. Etiology of 
chronic rhinosinusitis: the role of fungus. Ann 
Otol Rhinol Laryngol 113: 2004. 27-31. 
 
15. Carter KD, Graham SM and Carpenter KM. 
Ophthalmic manifestations of allergic fungal 
sinusitis. Am J Ophthalmol. 1999; 127: 189
 
 
 
 
